Clinical Trial: Trial of Sunitinib for Refractory Malignant Ascites

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Phase II Pilot Efficacy Trial of Sunitinib for Refractory Malignant Ascites

Brief Summary: The study is to see whether treatment with Sunitinib decreases the accumulation of ascites in patients with refractory malignant ascites.